| __timestamp | Cytokinetics, Incorporated | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 60987000 |
| Thursday, January 1, 2015 | 46398000 | 125542000 |
| Friday, January 1, 2016 | 59897000 | 210460000 |
| Sunday, January 1, 2017 | 90296000 | 275119000 |
| Monday, January 1, 2018 | 89135000 | 409539000 |
| Tuesday, January 1, 2019 | 86125000 | 547758000 |
| Wednesday, January 1, 2020 | 96951000 | 736300000 |
| Friday, January 1, 2021 | 159938000 | 904200000 |
| Saturday, January 1, 2022 | 240813000 | 1080300000 |
| Sunday, January 1, 2023 | 330123000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Unlocking the unknown
In the competitive world of biotechnology, understanding cost structures is crucial. This analysis compares the cost of revenue for Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated from 2014 to 2023. Over this period, Vertex Pharmaceuticals consistently outpaced Cytokinetics, with its cost of revenue growing by over 1,900%, reaching a peak in 2023. In contrast, Cytokinetics saw a more modest increase of approximately 640%.
This data highlights the differing strategies and market positions of these two biotech leaders, offering valuable insights for investors and industry analysts.
Cost of Revenue: Key Insights for Johnson & Johnson and Vertex Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Novartis AG vs Vertex Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs BeiGene, Ltd.
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG's Expenses
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Geron Corporation's Expenses
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Veracyte, Inc.'s Expenses
Cost of Revenue Comparison: Cytokinetics, Incorporated vs HUTCHMED (China) Limited
Cost of Revenue Trends: Cytokinetics, Incorporated vs Iovance Biotherapeutics, Inc.